版本:
中国

BRIEF-CATABASIS PHARMACEUTICALS ANNOUNCES POSITIVE PRECLINICAL DATA ON CAT-5571

June 8 Catabasis Pharmaceuticals Inc:

* CATABASIS PHARMACEUTICALS INC - ‍ANNOUNCES POSITIVE PRECLINICAL DATA ON CAT-5571, SUPPORTING ITS POTENTIAL AS AN ORAL TREATMENT FOR CYSTIC FIBROSIS​

* CATABASIS PHARMACEUTICALS -‍DATA DEMONSTRATE IMPROVED INTRACELLULAR CLEARANCE OF BACTERIA OF IMPORTANCE IN PATIENTS WITH CYSTIC FIBROSIS FOR CAT-5571​ Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐